SELLAS Life Sciences Group (SLS) Enterprise Value: 2011-2024
Historic Enterprise Value for SELLAS Life Sciences Group (SLS) over the last 9 years, with Sep 2024 value amounting to $59.4 million.
- SELLAS Life Sciences Group's Enterprise Value rose 135.90% to $59.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $29.3 million, marking a year-over-year increase of 198.76%. This contributed to the annual value of $73.2 million for FY2024, which is 132.70% up from last year.
- SELLAS Life Sciences Group's Enterprise Value amounted to $59.4 million in Q3 2024, which was down 11.90% from $67.4 million recorded in Q2 2024.
- SELLAS Life Sciences Group's 5-year Enterprise Value high stood at $127.4 million for Q2 2021, and its period low was $12.5 million during Q1 2020.
- For the 3-year period, SELLAS Life Sciences Group's Enterprise Value averaged around $41.8 million, with its median value being $31.5 million (2022).
- Its Enterprise Value has fluctuated over the past 5 years, first skyrocketed by 732.97% in 2020, then slumped by 77.02% in 2022.
- Over the past 5 years, SELLAS Life Sciences Group's Enterprise Value (Quarterly) stood at $113.9 million in 2020, then dropped by 25.45% to $84.9 million in 2021, then plummeted by 62.94% to $31.5 million in 2022, then declined by 0.02% to $31.5 million in 2023, then soared by 135.90% to $59.4 million in 2024.
- Its Enterprise Value was $59.4 million in Q3 2024, compared to $67.4 million in Q2 2024 and $38.4 million in Q1 2024.